Cargando…
Lanbotulinumtoxin‐A: Safe for children with cerebral palsy but is it effective?
This commentary is on the original article by Li et al. on pages 86‐93 of this issue.
Autores principales: | Hastings‐Ison, Tandy, Graham, Kerr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084364/ https://www.ncbi.nlm.nih.gov/pubmed/35746861 http://dx.doi.org/10.1111/dmcn.15329 |
Ejemplares similares
-
Botulinum Toxin in the Management of Children
with Cerebral Palsy
por: Multani, Iqbal, et al.
Publicado: (2019) -
Musculoskeletal Pathology in Cerebral Palsy: A Classification System and Reliability Study
por: Graham, H. Kerr, et al.
Publicado: (2021) -
Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study
por: Hastings-Ison, T., et al.
Publicado: (2018) -
Comparison of neurotoxic potency between a novel chinbotulinumtoxinA with onabotulinumtoxinA, incobotulinumtoxinA and lanbotulinumtoxinA in rats
por: Feng, Ya, et al.
Publicado: (2017) -
A novel investigation of eye‐gaze as an access method for children with dyskinetic cerebral palsy
por: Stadskleiv, Kristine
Publicado: (2022)